The FDA Remains Broken, Trasylol, a Case In Point

Trasylol is a drug that promotes clotting and is given during heart by pass surgery. It is one of the new and expensive biotech drugs of Bayer. Patients generally don’t know they are getting it, and it significantly increases kidney failure and the likelihood they will die at a significantly increased rate in the next few years following surgery. You can imagine that giving a clotting drug to patients with clogged arteries may have some problems. There are other options that are inexpensive and don’t carry the risks.

The Trasylol story is taking on the characteristics of a murder mystery. Bayer was found to be lying point blank to the FDA, intentionally covering up the risks. The FDA did nothing. An FDA advisory panel, known for their financial ties to Big Pharma, recently ruled Trasylol should stay on the market (no surprise – anything for profit).

A Canadian study on Trasylol was just halted, too many people died. The FDA does a press release and tells doctors to discuss the risks with their patients. Please – when will the FDA actually do its job and quit dumping its responsibility. The Justice Department should be investigating Bayer (or maybe they should be investigating FDA management) and the drug should be off the market.